共 75 条
[1]
Werdan K(1996)Supplemental immunoglobulins in sepsis: a critical appraisal. Clin Exp Immunol 104 S83-S90
[2]
Pilz G(1999)An enzyme immunoassay to determine the levels of specific antibodies toward bacterial surface antigens in human immunoglobulin preparations and blood serum. J Pharm Biomed Anal 20 913-920
[3]
Lamari F(1998)Bacterial lipopolysaccharide-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin Exp Immunol 111 81-90
[4]
Anastassiou ED(1999)Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg 584 S17-S25
[5]
Tsegenidis T(1999)Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 93 942-951
[6]
Dimitracopoulos G(1994)Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified post-cardiac patients at high risk for sepsis. Chest 105 76-82
[7]
Karamanos NK(1997)Comparison of early IgM-enriched immunoglobulin versus polyvalent IgG administration in score-identified post-cardiac surgical patients at high risk for sepsis. Chest 111 419-426
[8]
Trautmann M(1999)Reduced incidence of postoperative infections following intravenous application of an IgA and IgM-enriched immunoglobulin preparation in anergic patients undergoing cardiac surgery. Crit Care Med 27 1281-1287
[9]
Held TK(1997)Polyvalent immune globulins. Shock 7 A5/1918-26
[10]
Susa M(1988)Intravenous immunoglo-bulins in association with antibiotics: a therapeutic trial in septic intensive care unit patients. Crit Care Med 16 23-256